139 related articles for article (PubMed ID: 34121768)
1. Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An
Chaudhuri A
J Mol Struct; 2021 Nov; 1243():130854. PubMed ID: 34121768
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).
de Lima Menezes G; da Silva RA
J Biomol Struct Dyn; 2021 Sep; 39(15):5657-5667. PubMed ID: 32657643
[TBL] [Abstract][Full Text] [Related]
3. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
[TBL] [Abstract][Full Text] [Related]
4. Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.
Lokugamage KG; Narayanan K; Nakagawa K; Terasaki K; Ramirez SI; Tseng CT; Makino S
J Virol; 2015 Nov; 89(21):10970-81. PubMed ID: 26311885
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic.
Singh S; Zuwasti U; Haas C
Cureus; 2020 Nov; 12(11):e11310. PubMed ID: 33282586
[TBL] [Abstract][Full Text] [Related]
6. Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease.
Bosken YK; Cholko T; Lou YC; Wu KP; Chang CA
Front Mol Biosci; 2020; 7():174. PubMed ID: 32850963
[TBL] [Abstract][Full Text] [Related]
7. Structure of Nonstructural Protein 1 from SARS-CoV-2.
Clark LK; Green TJ; Petit CM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
[TBL] [Abstract][Full Text] [Related]
8. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs.
Min YQ; Mo Q; Wang J; Deng F; Wang H; Ning YJ
Front Microbiol; 2020; 11():587317. PubMed ID: 33133055
[TBL] [Abstract][Full Text] [Related]
10. Structure of nonstructural protein 1 from SARS-CoV-2.
Clark LK; Green TJ; Petit CM
bioRxiv; 2020 Nov; ():. PubMed ID: 33173873
[TBL] [Abstract][Full Text] [Related]
11. Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study.
Bhattacharya S; Banerjee A; Ray S
Int J Biol Macromol; 2021 Mar; 172():74-81. PubMed ID: 33385461
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
Thoms M; Buschauer R; Ameismeier M; Koepke L; Denk T; Hirschenberger M; Kratzat H; Hayn M; Mackens-Kiani T; Cheng J; Straub JH; Stürzel CM; Fröhlich T; Berninghausen O; Becker T; Kirchhoff F; Sparrer KMJ; Beckmann R
Science; 2020 Sep; 369(6508):1249-1255. PubMed ID: 32680882
[TBL] [Abstract][Full Text] [Related]
13. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
Nunnari G; Sanfilippo C; Castrogiovanni P; Imbesi R; Li Volti G; Barbagallo I; Musumeci G; Di Rosa M
Exp Cell Res; 2020 Oct; 395(2):112204. PubMed ID: 32735892
[TBL] [Abstract][Full Text] [Related]
14. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
Vankadari N; Jeyasankar NN; Lopes WJ
J Phys Chem Lett; 2020 Nov; 11(22):9659-9668. PubMed ID: 33135884
[TBL] [Abstract][Full Text] [Related]
15. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
Rui L; Haonan L; Wanyi C
Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Non-Structural Protein 1(NSP1) Mutation Virulence and Natural Selection: Evolutionary Trends in the Six Continents.
Salami Ghaleh S; Rahimian K; Mahmanzar M; Mahdavi B; Tokhanbigli S; Mollapour Sisakht M; Farhadi A; Mousakhan Bakhtiari M; Lee Kuehu D; Deng Y
bioRxiv; 2022 Jul; ():. PubMed ID: 35923310
[TBL] [Abstract][Full Text] [Related]
17. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach.
Bhatnager R; Bhasin M; Arora J; Dang AS
J Biomol Struct Dyn; 2021 Sep; 39(15):5690-5705. PubMed ID: 32619134
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV2 Nsp1 is a metal-dependent DNA and RNA endonuclease.
Salgueiro BA; Saramago M; Tully MD; Issoglio F; Silva STN; Paiva ACF; Arraiano CM; Matias PM; Matos RG; Moe E; Romão CV
Biometals; 2024 Mar; ():. PubMed ID: 38538957
[TBL] [Abstract][Full Text] [Related]
19. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
[TBL] [Abstract][Full Text] [Related]
20. MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA.
Terada Y; Kawachi K; Matsuura Y; Kamitani W
Virology; 2017 Nov; 511():95-105. PubMed ID: 28843094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
